A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/565 (2006.01) A61K 31/57 (2006.01)
Patent
CA 2057747
A contraceptive method and regimen utilizing an initially greater amount of progestogen, which gradually tapers over the period in which the contraceptive is administered. The regimen includes a multiphasic combi- nation and contraceptive kit containing at least 21 daily sequential dosage units divided into 3 phases. The first phase contains 6-8 dosage units, each contain- ing a progestogen at a dosage equivalent in pro- gestogenic activity to 75-150 µg desogestrel and an estrogen at a dosage equivalent in estrogenic activity to 20-25 µg ethinyl estradiol. The second phase con- tains 6-8 dosage units, each containing less progestogen than in the previous dosage units, but still having pro- gestogen equivalent to 75-125 µg desogestrel and an estrogen equivalent to 20 µg ethinyl estradiol. The third phase contains 6-8 dosage units, each containing less progestogen than in the previous dosage units, but still containing a progestogen equivalent to 75-100 µg desogestrel and an estrogen equivalent to 20 µg ethinyl estradiol. The kit may also include another phase of 4 to 7 dosage units having no contraceptive steroid.
Akzo N.v.
Fetherstonhaugh & Co.
LandOfFree
Contraceptive regimen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Contraceptive regimen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Contraceptive regimen will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1731117